Zenagamtide for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Nov 2026: Trial registered, NCT07931573

The trials

NCT07931573: AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both

State
Not started
Phase
Phase 3
People
1,200 planned
Started
10 Nov 2026
Primary completion
4 Jul 2028
Arms
Zenagamtide
Results
None posted
  1. 12 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.